Urología
Especialidad
![Foto de Urología](/img/noimage.png)
![Foto de Hospital Universitario Virgen de las Nieves](/img/noimage_org.png)
Hospital Universitario Virgen de las Nieves
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (18)
2024
-
Why is it necessary to produce a BCG strain in Spain?
Actas Urologicas Espanolas
2023
-
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer
Actas Urologicas Espanolas, Vol. 47, Núm. 2, pp. 111-126
-
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply
Actas Urologicas Espanolas
-
Hormone sensitive protocol for metastatic prostate cancer, an update
Actas Urologicas Espanolas, Vol. 47, Núm. 4, pp. 244-249
2022
-
Non-metastatic castration-resistant prostate cancer: management recommendations
Actas Urologicas Espanolas, Vol. 46, Núm. 4, pp. 193-213
2020
-
Cirugía de urgencia en urología durante la pandemia Covid-19
Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 353-359
2018
-
Actualización del papel de la quimioterapia endovesical en el cáncer de vejiga no músculo-invasivo
Actas Urologicas Espanolas
-
Radio-223 en la secuencia terapéutica del cáncer de próstata resistente a la castración metastásico
Actas Urologicas Espanolas
-
Review of evidence on handling hazardous drugs and Products in Urology Services; Consensus document between the Spanish Urology Association and the Spanish Society of Health-System Pharmacists
Biomedical Instrumentation and Technology, Vol. 42, Núm. 5, pp. 212-215
-
Review of the evidence on handling drugs and hazardous products in Urology Departments. Consensus document between the Spanish Urological Association and the Spanish Society of Hospital Pharmacy
Actas Urologicas Espanolas, Vol. 42, Núm. 6, pp. 375-380
-
Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice
Actas Urologicas Espanolas, Vol. 42, Núm. 4, pp. 238-248
2017
-
Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study
International Journal of Radiation Oncology Biology Physics, Vol. 98, Núm. 3, pp. 590-594
-
Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study – GESCAP group
Actas Urologicas Espanolas, Vol. 41, Núm. 6, pp. 359-367
2016
-
Tendencias de tratamiento en el cáncer de próstata clínicamente localizado. Análisis poblacional a nivel nacional: grupo GESCAP
Actas Urologicas Espanolas, Vol. 40, Núm. 4, pp. 209-216
2014
-
Bladder cancer index: Cross-cultural adaptation into Spanish and psychometric evaluation
Health and Quality of Life Outcomes, Vol. 12, Núm. 1
2013
-
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
British Journal of Cancer, Vol. 109, Núm. 1, pp. 121-130
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572
2011
-
Prostate cancer in Spain: From guidelines to clinical practice
BJU International, Vol. 108, Núm. 1, pp. 61-66